CME Instructions

Cardiology Review® OnlineJune 2014
Volume 30
Issue 3

CME Reviews: Volume 30, No. 3

Release date: June 16, 2014

Expiration date: June 16, 2015

Media used: Internet-based

Estimated time to complete this CME activity: 1 hour

Statement of Need

Cardiovascular disease (CVD) is the leading cause of death in the United States. It is estimated that 83 million American adults have 1 or more forms of CVD. New agents, procedures, and interventions have improved patient outcomes with decreased mortality and morbidity rates. However, as the population ages and as younger adults are developing comorbidities due to unhealthy lifestyles, the patient population at risk for cardiovascular events is increasing.

Care for patients with CVD has become increasingly complex, and community-based cardiologists often struggle to stay up-to-date with the volume of new data. The overall goals of this publication are to provide timely and pertinent original research articles that review current guidelines, practices, and new developments in the field of cardiovascular medicine. The publication also emphasizes preventing CVD by modifying risk factors through such strategies as healthy eating, regular exercise, and avoidance of smoking.

Target Audience

The target audience for this activity is cardiologists.

CME Learning Objectives

At the conclusion of this activity, participants should be able to:

  1. Assess the findings of Sherwood and colleagues’ study of transfusion in patients undergoing PCI and how the data apply to transfusion strategies for individual patients.
  2. Compare and contrast the outcomes of mitral valve repair versus mitral valve replacement in the study by Acker et al in the treatment of ischemic mitral regurgitation.
  3. Consider the evidence from the Digitalis Investigation Group and other trials on digoxin and whether digoxin should be reconsidered in patients with worsening heart failure.
  4. Analyze the evidence from Stefanini and colleagues’ trial of newer-generation drug-eluting stents in women.
  5. Assess the evidence on the association between anger and cardiovascular events.

Financial Disclosure

As a sponsor accredited by the ACCME, it is the policy of Physicians’ Education Resource®, LLC (PER®), to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants prior to the beginning of each CME activity. PER® has identified and resolved all conflicts of interest prior to the release of this activity.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

Sources of Funding

No educational grants from commercial interests were received.

Instructions for Receiving Credit

In order to receive a CME certificate for this activity, participants must

  • Take the pretest and record their answers online at
  • Read each review.
  • Take the posttest and record their answers online at A passing score of 70% or higher is required to obtain a CME certificate.
  • Complete the CME activity evaluation at Participants can immediately download their CME certificates upon successful passing of the posttest and completion of the CME activity evaluation.

Accreditation and Designation of Credit

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Debabrata Mukherjee, MD, MS, FACC

Chief, Cardiovascular Medicine

Clinical and Research Fellow

Vice Chairman, Department of Internal Medicine

Texas Tech University Health Sciences Center

El Paso, TX

Aparna M. Bhagavat, MD, FACC

Noninvasive Cardiologist

San Mateo Multispecialty Physicians Group

San Mateo County Hospital

San Mateo, CA

Pareena Bilkoo, MD, FACC

Interventional Cardiologist

Director, Cardiac Catheterization Laboratory

East Georgia Regional Medical Center

Statesboro, GA

Leslie A. Campbell, MD

Director, Advanced Heart Failure & Transplant

Barry S. Levin, M.D. Department of Transplantation

California Pacific Medical Center

San Francisco, CA

Nezar Falluji, MD, MPH, FACC, FSCAI

Interventional Cardiologist

Executive Director, Kentucky One Health

Cardiovascular Service Line

Co-director, Transcatheter Valve Program

Saint Joseph Heart and Vascular Institute

Lexington, KY

Diana Fancher, DNP, MBA, RN

Chief Nursing Officer

University Medical Center of El Paso

El Paso, TX

Icilma Fergus, MD, FACC

Associate Professor of Medicine

Director, Cardiovascular Disparities

Mount Sinai School of Medicine

New York, NY

Harold L. Lazar, MD

Professor of Cardiothoracic Surgery

Boston University School of Medicine

Boston, MA

The following individuals have no relevant financial relationships with commercial interests to disclose:

Authors: Aparna M. Bhagavat, MD, FACC; Pareena Bilkoo, MD, FACC; Leslie A. Campbell, MD; Nezar Falluji, MD, MPH, FACC, FSCAI; Diana Fancher, DNP, MBA, RN; Icilma Fergus, MD, FACC; Harold L. Lazar, MD.

Planner, reviewer, and editor-in-chief: Debabrata Mukherjee, MD, MS, FACC

PER planners and staff: Megan O’Connell; Emily Valko

Cardiology Review staff: Bea Riemschneider; Jackie Syrop

Provider Contact Information:

Physicians’ Education Resource®, LLC

666 Plainsboro Road, Suite 356

Plainsboro, NJ 08536

Toll Free: 888-949-0045

Local: 609-378-3701

Fax: 609-257-0705

Related Videos
Video 5 - "Real-World Insights: Navigating Cardiac Myosin inhibitors in Practice" - Featuring 1 KOL
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Video 4 - "Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal Outcomes "
Video 3 - "Aligning With 2023 ESC Guidelines in oHCM Treatment"
Robert Rosenson, MD | Credit: Cura Foundation
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Robert Rosenson, MD | Credit: Cura Foundation
Video 2 - "Lessons from EXPLORER-HCM: Unveiling CMIs' Potential in oHCM Treatment "
© 2024 MJH Life Sciences

All rights reserved.